While large studies have shown that soluble MUC1 is a predictor of prognosis for both early and advanced tumor stages independently of the tumor stage [7,9,15], it may be hypothesized that the close association between tumor stage and MUC1 is due to the fact that MUC1 levels mirror the tumor burden in BC patients. The gene discussed is MUC1; the disease is neoplasm.